Seeing Is Believing
Currently out of the existing stock ratings of Ross Muken, 83 are a BUY (60.58%), 5 are a SELL (3.65%), 49 are a HOLD (35.77%).
Analyst Ross Muken, currently employed at EVERCORE, carries an average stock price target met ratio of 86.11% that have a potential upside of 17.27% achieved within 561 days.
Ross Muken’s has documented 276 price targets and ratings displayed on 31 stocks. The coverage is on Healthcare, Financial Services sectors.
Most recent stock forecast was given on CRL, Charles River Laboratories at 25-Sep-2026.
Analyst best performing recommendations are on RAD (RITE AID).
The best stock recommendation documented was for PDCO (PATTERSON COMPANIES) at 6/21/2018. The price target of $18.5 was fulfilled within 1 day with a profit of $0.73 (4.11%) receiving and performance score of 41.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 02-Feb-2018
$260
$26.67 (11.43%)
$250
16 days ago
(21-Sep-2026)
21/23 (91.3%)
$15.12 (6.17%)
347
Hold Since 22-Apr-2022
$245
$11.67 (5.00%)
$220
29 days ago
(08-Sep-2026)
21/21 (100%)
$9.5 (4.03%)
268
Hold Since 30-May-2024
$250
$16.67 (7.14%)
$190
2 months 9 days ago
(28-Jul-2026)
3/4 (75%)
$14.06 (5.96%)
213
Buy Since 22-Apr-2026
$250
$16.67 (7.14%)
$230
2 months 13 days ago
(24-Jul-2026)
2/3 (66.67%)
$22.14 (9.72%)
62
Buy Since 26-Apr-2017
$260
$26.67 (11.43%)
$235
2 months 13 days ago
(24-Jul-2026)
28/29 (96.55%)
$32.14 (14.11%)
553
Which stock is Ross Muken most bullish on?
Which stock is Ross Muken most reserved on?
What Year was the first public recommendation made by Ross Muken?